Equity Capital Markets

Company · CIK 1800315

Damora Therapeutics, Inc.

CIK1800315 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
ListedDMRA (Nasdaq)
First annual or quarterly report2020-12-11

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-292175
ShelfEffective
 2025-12-162026-08-123
333-293343
ShelfEffective
 2026-02-102026-02-113
333-260778
ShelfEffective
 2021-11-042023-03-094
333-249369
IPOFinal prospectus
 2020-10-072020-10-304

Filings

15
FiledFilingRegistrationAccession
2026-08-12EFFECTDeclared effective 333-2921759999999995-26-002630
2026-02-11424B5Shelf takedown 333-2933430001193125-26-046779
2026-02-10424B5Shelf takedown 333-2933430001193125-26-044766
2026-02-10S-3ASRShelf registered 333-2933430001193125-26-044613
2025-12-23EFFECTDeclared effective 333-2921759999999995-25-003922
2025-12-16S-3Shelf registered 333-2921750001193125-25-321093
2023-03-09424B5Shelf takedown 333-2607780000950170-23-006820
2022-02-18424B5Shelf takedown 333-2607780001564590-22-005716
2021-11-12EFFECTDeclared effective 333-2607789999999995-21-004331
2021-11-04S-3Shelf registered 333-2607780001564590-21-054556
2020-10-30424B4Final prospectus 333-2493690001193125-20-282633
2020-10-28EFFECTDeclared effective 333-2493699999999995-20-003010
2020-10-22S-1/AAmendment 333-2493690001193125-20-273986
2020-10-07S-1Registration filed 333-2493690001193125-20-265628
2020-09-02DRSDraft made public 377-034900000950123-20-009492

All filings of this company · CSV